2.36 USD
-3.62 (-60.54%)
2.4 USD
+0.04 (+1.69%)
Overall CODX gets a fundamental rating of 4 out of 10. We evaluated CODX against 186 industry peers in the Health Care Equipment & Supplies industry. CODX has a great financial health rating, but its profitability evaluates not so good. CODX is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year CODX has reported negative net income.
- CODX had a negative operating cash flow in the past year.
- In multiple years CODX reported negative net income over the last 5 years.
- In multiple years CODX reported negative operating cash flow during the last 5 years.
1.2 Ratios
- The Return On Assets of CODX (-71.93%) is worse than 73.66% of its industry peers.
- CODX has a Return On Equity of -80.80%. This is comparable to the rest of the industry: CODX outperforms 40.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -71.93% | ||
| ROE | -80.8% | ||
| ROIC | N/A |
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CODX's Gross Margin of 34.04% is on the low side compared to the rest of the industry. CODX is outperformed by 74.73% of its industry peers.
- CODX's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for CODX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
2. Health
2.1 Basic Checks
- CODX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for CODX has been increased compared to 1 year ago.
- The number of shares outstanding for CODX has been increased compared to 5 years ago.
- CODX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- CODX has an Altman-Z score of 13.52. This indicates that CODX is financially healthy and has little risk of bankruptcy at the moment.
- CODX's Altman-Z score of 13.52 is amongst the best of the industry. CODX outperforms 92.47% of its industry peers.
- There is no outstanding debt for CODX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 13.52 |
ROIC/WACCN/A
WACC10%
2.3 Liquidity
- CODX has a Current Ratio of 3.81. This indicates that CODX is financially healthy and has no problem in meeting its short term obligations.
- CODX has a Current ratio of 3.81. This is in the better half of the industry: CODX outperforms 66.67% of its industry peers.
- CODX has a Quick Ratio of 3.51. This indicates that CODX is financially healthy and has no problem in meeting its short term obligations.
- With a decent Quick ratio value of 3.51, CODX is doing good in the industry, outperforming 70.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.81 | ||
| Quick Ratio | 3.51 |
3. Growth
3.1 Past
- The earnings per share for CODX have decreased strongly by -1416.54% in the last year.
- The Revenue for CODX has decreased by -93.06% in the past year. This is quite bad
- The Revenue has been growing by 79.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1416.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
Revenue 1Y (TTM)-93.06%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-77.38%
3.2 Future
- CODX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.41% yearly.
- Based on estimates for the next years, CODX will show a very strong growth in Revenue. The Revenue will grow by 101.21% on average per year.
EPS Next Y-1795.58%
EPS Next 2Y-231.17%
EPS Next 3Y-121.26%
EPS Next 5Y51.41%
Revenue Next Year-88.3%
Revenue Next 2Y-62.71%
Revenue Next 3Y60.7%
Revenue Next 5Y101.21%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CODX. In the last year negative earnings were reported.
- Also next year CODX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as CODX's earnings are expected to decrease with -121.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-231.17%
EPS Next 3Y-121.26%
5. Dividend
5.1 Amount
- No dividends for CODX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CO-DIAGNOSTICS INC / CODX FAQ
What is the ChartMill fundamental rating of CO-DIAGNOSTICS INC (CODX) stock?
ChartMill assigns a fundamental rating of 4 / 10 to CODX.
What is the valuation status of CO-DIAGNOSTICS INC (CODX) stock?
ChartMill assigns a valuation rating of 0 / 10 to CO-DIAGNOSTICS INC (CODX). This can be considered as Overvalued.
What is the profitability of CODX stock?
CO-DIAGNOSTICS INC (CODX) has a profitability rating of 1 / 10.
How financially healthy is CO-DIAGNOSTICS INC?
The financial health rating of CO-DIAGNOSTICS INC (CODX) is 8 / 10.